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022 The Journal of Thoracic and Cardbjective: Although radiofrequency ablation is increasingly used to create the atrial
esions of the Cox maze procedure, its effectiveness in ablating atrial fibrillation
ompared with the standard cut-and-sew method is not known. We compare the
reedom from atrial fibrillation in patients undergoing both methods with identical
esion sets.
ethods: Radiofrequency ablation was used to create full Cox maze lesions in 56
atients between January 2002 and February 2005; these patients were matched with
hose who underwent the standard cut-and-sew method. Matched variables were gender
33 male, 23 female, both), age (67.5 vs 67.2 years), New York Heart Association class
mean 2.28 vs 1.96), atrial fibrillation type (37 paroxysmal, 19 continuous, both), and
oncomitant mitral valve surgery (37 in both). Hypertension, preoperative left atrial size,
nd preoperative duration of atrial fibrillation were similar between groups.
esults: When compared with matched controls, fewer patients undergoing radio-
requency ablation were free from atrial fibrillation at dismissal (63% vs 88%; P 
0039) and at last follow-up (62% vs 92%; P  .016). According to logistic
egression for matched pairs, patients undergoing radiofrequency ablation were 4.5
imes more likely to be in atrial fibrillation at dismissal (95% confidence intervals
CI], 1.8, 10.9) and 5 times more likely to be in atrial fibrillation at follow-up (95%
I, 1.4, 17.3). No other covariate was associated with atrial fibrillation status at
ospital dismissal or follow-up.
onclusion: Creating Cox maze lesions with radiofrequency ablation is associated with
ess freedom from atrial fibrillation both early and late postoperatively. Because trans-
urality can be assured, the standard cut-and-sew Cox maze procedure remains the gold
tandard for the surgical treatment of atrial fibrillation.
he classic cut-and-sew (CS) Cox maze III procedure is widely established as
effective for the surgical treatment of atrial fibrillation (AF). However, its
widespread adoption has been inhibited by its technical complexity. Alter-
ate energy sources and alternate lesion sets have been proposed and used clinically
n the interest of simplifying the procedure.1-4 Both on-pump and off-pump maz
ike procedures have been described with epicardial as well as endocardial appli-
ation of energy.5,6 The impact of these modifications on the effectiveness of c
F, however, remains unclear.
The largest clinical experience using alternate energy sources is with radiofre-
uency (RF) ablation, which uses alternating current to transfer energy to atrial
issue. Success of this technology in the catheterization laboratory has led surgeons
o apply RF directly to the heart during cardiac surgery.7-9 Several instruments hav
een developed to create atrial lesions, including rigid unipolar probes with cooled
ips,10,11 flexible unipolar probes,12 and bipolar clamps with13 and without
rrigation.14
iovascular Surgery ● April 2007
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A
CDDespite reports of successful ablation of AF with these
ew instruments and techniques, the effectiveness of RF
ompared with the standard CS maze procedure has not
een clearly demonstrated. Analysis of results is further
omplicated by variable definitions of success. We sought
o more precisely evaluate the impact of one ablation tech-
ology by direct comparison with the CS technique using a
ase-matched study design holding the lesion set constant
nd evaluating cure by several clearly defined criteria.
atients and Methods
rom January 2002 to February 2005, 56 patients underwent
reation of the full atrial lesion sets as described by Cox and
ssociates15 using bipolar RF ablation. The pulmonary veins w
blated in identical fashion to the manner in which the pulmonary
ein–encircling incision is created in the CS maze, and RF was
sed to create the connecting lesion to the mitral valve. Cryole-
ions were placed at both the mitral and tricuspid valve annuli, as
n the CS maze. The transseptal lesion was created with a line of
ryolesions to avoid injury to the blood supply to the sinoatrial
ode. We use this modification as part of our lesion set for the CS
aze. The lesion sets were identical between the RF and CS
roups, as were the placement of cryolesions. The only difference
etween the two procedures was in the method of creating the
trial lesions.
These patients were strictly matched with 56 patients from a
atabase of 335 patients who underwent the classic CS Cox maze
rocedure at our institution between March 1993 and December
002. Medical records were reviewed for patient demographics,
ast cardiac medical and surgical history, operative procedure,
reoperative and postoperative cardiac rhythm, early and late
orbidity, and survival.
Matched variables were gender, age, New York Heart Associ-
tion (NYHA) class, AF type, and concomitant mitral valve as
ABLE 1. Matched variables between treatment groups
ariable RF CS P value
ale 33 (59%) 33 (59%)
ge range (y) 39-84 38-80
edian age (y) 67.5 67.2 .87
YHA class 2.28 1.96 .07
hronic AF 37 (66%) 37 (66%)
V surgery 37 (66%) 37 (66%)
F, Radiofrequency maze group; CS, cut-and-sew maze group; NYHA, New
Abbreviations and Acronyms
AF  atrial fibrillation
CI  confidence interval
CS  cut-and-sew
NYHA New York Heart Association
RF  radiofrequencyork Heart Association; AF, atrial fibrillation/flutter; MV, mitral valve. m
The Journal of Thoracichown in Table 1. Additional variables potentially affecting 
ome, including hypertension (RF vs CS) (23 vs 22 patients; P 
85), left atrial size (67.5 vs 66.7 mm; P  .799), and preoperative
uration of AF (52 10 vs 67 4 months; P .69), were similar
etween groups.
tatistical Analysis
emographic and other patient-related data were obtained
rom Mayo Clinic medical records. Follow-up information
as obtained from subsequent clinic visits, written corre-
pondence from local physicians, and mailed questionnaires
o patients or families. Rhythm was evaluated by electro-
ardiograms obtained during clinical follow-up. Data were
xpressed as both median with a range and mean standard
eviation. A multivariable analysis (logistic regression for
atched pairs) was used to identify factors for AF recur-
ence (hospital dismissal and last follow-up), normal sinus
hythm status (hospital dismissal and last follow-up), and
eed for postoperative permanent pacemaker. A Kaplan–
eier curve was generated to delineate time-related recur-
ence of AF. Early operative mortality was defined as death
ccurring within 30 days of operation or at any time during
he index hospitalization. The Mayo Foundation Institu-
ional Review Board approved this study, and all patients or
heir families gave written informed consent.
esults
perative details are shown in Table 2. A classic Cox 
rocedure was performed in all 56 patients with bipolar RF
blation (AtriCure device [AtriCure, Inc, Cincinnati, Ohio]
n 50; Medtronic device [Medtronic, Inc, Minneapolis,
inn] in 6) to create the full Cox maze lesion sets. Six
ifferent surgeons performed the RF maze procedure on
hese 56 patients, and these same surgeons performed the
S maze as well. All patients had concomitant procedures
erformed, with more tricuspid valve interventions in the
F group (P  .02). There was a trend toward more aortic
alve procedures and septal myectomies among the RF
roup as well. Mean crossclamp time was similar between
reatment groups (RF vs CS) (65  6 minutes vs 71  4
inutes; P  .6), as was total bypass time (98  6 minutes
s 101  7 minutes; P  .54).
ABLE 2. Concomitant procedures performed
rocedure RF CS P value
V surgery 14 (25%) 5 (9%) .02
V surgery 11 (20%) 4 (7%) .05
ABG 13 (23%) 11 (20%) .63
eptal myectomy 6 (11%) 1 (2%) .05
V surgery 37 (66%) 37 (66%) 1.0
F, Radiofrequency maze group; CS, cut-and-sew maze group; TV, tricus-
id valve; AV, aortic valve; CABG, coronary artery bypass grafting; MV,
itral valve.
and Cardiovascular Surgery ● Volume 133, Number 4 1023
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A
CDThere were no early deaths in either group. Early non-
atal morbidity in the RF group included postoperative AF
n  24, 43% of early survivors), cerebrovascular accident
n  2), and ventricular arrhythmias, respiratory insuffi-
iency, and complete heart block in 1 patient each. In the CS
roup, postoperative AF occurred in 24% (n  13) of early
urvivors (P  .05 vs RF group), and cerebrovascular
ccident, ventricular arrhythmias, and respiratory insuffi-
iency occurred in 1 patient each. Reoperation for medias-
inal bleeding was required in 2 RF patients and none of the
S patients. Two RF patients required reoperation for post-
perative mitral valve (n  1) and tricuspid valve regurgi-
ation (n  1).
Freedom from AF at dismissal was significantly lower in
he RF group than in the CS group (64% vs 88%; P 
0039). According to a multivariable model, patients in the
F group were 4.5 times more likely to be in AF at hospital
ismissal. The use of RF ablation was the only significant
redictor of AF status at dismissal (RF, P  .011; tricuspid
alve surgery, P  .6031; aortic valve surgery, P  .4643;
eptal myectomy, P  .8184).
New permanent pacemaker implantation was required in
ignificantly more patients in the RF group than in the CS
roup (25% vs 5%; P  .004). In the RF group, indications
or permanent pacemaker implantation were sinus node
ysfunction in 12 patients, long QT syndrome in 1, and
omplete heart block in 1. In the CS group, permanent
acemaker implantation was required for sinus node dys-
unction in all 3 patients. According to a multivariable
odel, patients in the RF group were 4 times more likely to
e dismissed with a new permanent pacemaker (P  .02).
Of the 56 early survivors, 8 were lost to follow-up in the
F group and 2 in the CS group. Late follow-up extended
p to 33 months (mean 8.4 months, median 8 months).
ollow-up results of these 48 patients were then compared
ith their respective 48 matched controls from the CS
roup. The CS control matches for the 8 RF patients lost to
ollow-up were excluded from comparison. Although the
S maze patients had a longer follow-up period, “rhythm at
ast follow-up” was defined as last follow-up for the RF
aze patients and their respective matches from the CS
roup at the same period in time postoperatively. In addi-
ABLE 3. Freedom from AF according to three different
ethods of reporting
Interval contact Actuarial
roup Last FU 6 mo 12 mo 15 mo 6 mo 12 mo 15 mo
F 62% 75% 62% 50% 87% 76% 61%
S 92% 91% 91% 91% 94% 91% 91%
F, Atrial fibrillation; RF, radiofrequency ablation group; CS, cut-and-sew
aze group; FU, follow-up.ion, when RF patients ceased follow-up, their respective 9
024 The Journal of Thoracic and Cardiovascular Surgery ● AprS matches were excluded from analysis from that point
nward. Patients available for follow-up in the RF group
ncluded 48 at 3 months, 26 at 6 months, 18 at 9 months, 12
t 12 months, and 12 at 15 months. There were 2 late deaths
n the RF group resulting from noncardiac causes (malig-
ancy in 1 and pneumonia in 1). Both patients were in AF
efore death. There were no late deaths in the CS group.
Antiarrhythmic medications at last follow-up were re-
uired in 36 (75%) patients in the RF ablation group and 12
25%) patients in the CS control group (P .05). Forty-one
85%) patients in the RF ablation group were still receiving
arfarin anticoagulation at last follow-up compared with 12
25%) patients in the CS control group (P  0.05).
Success of the procedure in treating AF was evaluated as
hythm at last follow-up, by actuarial methods, and by
hythm at interval contact (Table 3). Freedom from A
ast follow-up was significantly lower in the RF ablation
roup than in the CS control group (62% vs 92%; P 
0157). According to a multivariable model, RF ablation
atients were 5 times more likely to be in AF at follow-up
95% confidence intervals [CI]: 1.447, 17.267), and no
ovariate other than use of RF ablation was associated with
resence of AF at last follow-up. Similarly, sinus rhythm at
ast follow-up was significantly less common in the RF
blation group than in the CS control group (43% vs 85%;
 .00002). According to a multivariable model, CS
blation patients were 10.5 times more likely to be in
ormal sinus rhythm at follow-up (95% CI: 2.46, 45.45),
nd no covariate other than the use of RF ablation was
ssociated with a decreased rate of sinus rhythm at last
ollow-up.
Use of a Kaplan–Meier curve to delineate time-related
vents shows that freedom from AF was 91% for the CS
aze control group versus 87% for the RF ablation group at
months and 91% for the CS maze control group versus
6% for the RF ablation group (P  .05) at 12 months
Figure 1). Reporting outcome as rhythm at 6-, 12-,
5-month interval follow-up periods, freedom from AF was
igure 1. Actuarial freedom from AF between the RF and CS maze
roups. Significance (P < .05) was detected at 12 and 15 months
etween treatment groups. AF, atrial fibrillation; RF, radiofre-
uency ablation group; CS, cut-and-sew.1% for the CS maze control group versus 75% for the RF
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A
CDblation group at 6 months, 91% for the CS maze control
roup versus 62% for the RF ablation group (P  .05) at 12
onths, and 91% for the CS group versus 50% (P .05) for
he ablation group at 15 months (Figure 2).
onclusions
n this study, the use of RF energy for the creation of the
trial lesions of the Cox maze procedure was associated
ith significantly less freedom from AF both at hospital
ismissal and at follow-up as defined by rhythm at last
ollow-up, actuarial freedom from AF, and rhythm at inter-
al follow-up. Importantly, although this trend was consis-
ent, the reported “success” of the procedure as defined by
ach of these methods differs. Patients in the RF ablation
roup were 4.5 times more likely to be dismissed from the
ospital in AF and 5 times more likely to be in AF at the
ime of last follow-up. In a multivariable model, the only
redictor for AF status at hospital dismissal and follow-up
as the use of RF ablation at the time of the maze proce-
ure. Further, patients in the CS cohort were twice as likely
o be in sinus rhythm at hospital dismissal and 10.5 times
ore likely to be in sinus rhythm at follow-up. A recent
eta-analysis of patients undergoing both the classic CS
aze procedure and alternate energy sources demonstrates
n 85.3% postoperative sinus rhythm rate for CS versus a
9.7% sinus rhythm rate when alternate energy is us16
he current study demonstrates a much higher discrepancy
etween the two techniques.
A surprising finding of this study was that new permanent
acemaker implantation was required in significantly more
atients in the RF group than in the CS group. Although the RF
roup underwent more tricuspid valve operations, as well as
ortic valve replacements and septal myectomies, by mul-
ivariate analysis these were not significant predictors of
ew pacemaker implantation. Complete heart block would
ave been the expected indication for permanent pacemaker
igure 2. Freedom from AF at interval contact between the RF and
S maze (RFM and CSM) groups. Significance (P < .05) was
etected at 12 and 15 months between treatment groups. AF, atrial
brillation; RF, radiofrequency ablation group; CS, cut-and-sew.mplantation if increased tricuspid valve surgery, aortic a
The Journal of Thoracicalve surgery, or septal myectomy placed the patient at
igher risk for permanent pacemaker need. However, in
hese patients, the major indication for permanent pace-
aker implantation was sick sinus syndrome. Perhaps the
atients in the RF group represented a group with greater
nderlying cardiac disease (as evidenced by more concom-
tant procedures performed), and thus a higher incidence of
ick sinus syndrome when AF was ablated.
Prior studies have documented that AF can be surgically
blated by RF energy.17-20 The comparative effectivenes
ith conventional surgical lesions, however, has not been
reviously subjected to case-matched comparison. There
re theoretical reasons why these new RF ablation technol-
gies may be less effective. Achieving and ensuring trans-
urality of lesions may be complicated by differences in
trial tissue characteristics (thickness, fibrosis, fat) as well
s operative techniques (normothermia vs hypothermia,
eating heart vs arrested heart). The unpredictability of
onditions at the time of ablation will undoubtedly affect the
uality of the lesions regardless of the energy source used.
t is impossible to apply uniform energy and uniform tech-
iques to atria that offer considerable variability. We con-
inue to use cryolesions at the mitral and tricuspid valve
nnuli and to create the transseptal lesion, similar to our
pproach in the standard CS procedure. A different algo-
ithm was used with the AtriCure device using two ablations
o satisfactorily achieve a transmural lesion. We do not
outinely evaluate transmurality by measuring electrophysi-
logic isolation of the pulmonary veins at the time of
blation, and there remains a question as to whether this
quates with transmurality. Conversely, ablation procedures
ave been reported to convey high rates of success despite
demonstrably or even intentionally incomplete pulmonary
ein encircling lesion.21
The literature on surgical treatment options for AF is
omplicated by multiple criteria for defining success. In our
tudy, we report rhythm at last follow-up, actuarial freedom
rom AF, and rhythm at interval contact. In all instances, the
esults with CS were superior to RF, but the apparent “cure”
ate differed among methods. These data highlight some of
he difficulties in comparing reports of series of patients
ndergoing the Cox maze procedure or any other treatment
or AF. It is therefore critical that criteria be clearly defined
nd that results be reported and analyzed in a uniform
anner.
The retrospective, nonrandomized nature of this study is
major limitation. Although the groups were matched for
emographics and clinical characteristics, there were differ-
nces in concomitant procedures performed that may have
ffected outcome. Additionally, although we report success
n three ways, only electrocardiograms were analyzed and
olter monitoring was not performed. A significant percent-ge of AF may be entirely asymptomatic.22 In addition,
and Cardiovascular Surgery ● Volume 133, Number 4 1025
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A
CDlthough follow-up was also case-matched (matched con-
rols were censored when RF patients ceased follow-up),
here were a significant number of patients who lacked
ong-term follow-up. To account for this, we also reported
uccess in a Kaplan–Meier analysis. The RF group repre-
ents the institution’s first 56 patients in whom RF was used
o create the maze lesion set. Individual surgeon learning
urve, as well as a potential institutional learning curve,
ay have influenced our results when compared with other
urgical series using RF. However, analysis of individual
urgeon outcome, as well as analyzing the first group of 28
rocedures and the second group of 28 procedures per-
ormed, did not yield any significant differences in outcome.
espite these shortcomings, the principal strength of this
tudy is the consistency in the lesion set, leaving only lesion
reation source as a variable.
The underlying mechanism for the observed difference
n results may or may not be completely attributable to a
ack of transmurality, but comparative studies such as this
ne raises important issues for consideration for future
tudies. Most important, the discrepancy in reported results
or ablation tools is most likely multifactorial (differing
echniques, differing methods of assessment and reporting
uccess) and the ultimate clinical impact of transmurality
nd selection of lesion set is not completely understood.*
ore comparative studies are required to compare not only
he efficacy of products from different companies, but also
ifferent alternate energy sources used. The ultimate goal in
ddressing these issues is to develop more successful abla-
ion procedures.
If the indication for operation is medically refractory AF,
he CS Cox maze operation offers the patient the highest
hance at freedom from AF. However, the use of RF while
erforming concomitant operations may simplify the proce-
ure significantly but at the expense of a potentially lower
hance of ablation of AF.
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CDiscussion
r Cliff K. Choong (Cambridge, United Kingdom). Among the
atients who underwent the RF ablation, did you and your co-
nvestigators do any intraoperative assessment to confirm trans-
urality of the ablation lines at all? Second, why do you think
here is a difference in these results between the two groups? Last,
n the basis of your findings, how has that influenced the practice
t the Mayo Clinic?
Dr Stulak. Intraoperatively, it seemed in this patient popula-
ion that RF was used mostly in patients who had numerous
oncomitant procedures. Because it is very time-consuming, we do
ot measure conduction block intraoperatively. It is hard to know
hy we saw the striking differences between the two procedures
hat we did. It is hard to know whether it is purely due to a
otential lack of transmurality. There are numerous factors that
ay contribute, including differences in the atrial characteristics in
erms of thickness, fibrotic scar in older patients, the amount of fat
round the pulmonary veins, as well as intraoperative factors such
s normothermia versus hypothermia, beating heart, endocardial
ersus epicardial. We think that it is impossible to apply uniform
nergy in a uniform fashion to atria that have very different
haracteristics. In our practice, although we believe that RF can be
sed as part of a concomitant procedure, if the indication for
peration is purely AF, CS offers the patient the best relief of AF.
Dr Niv Ad. (Falls Church, Va). It was a wonderful paper.
owever, I think we should be very careful in interpreting the
esults, and this is why. By matching the patients, I think you made
crucial mistake. We all know that one of the most important and
ignificant factors contributing to the failure of the maze procedure
s the duration of AF before surgery. I did not see any matching
etween these two very significant parameters; that is, the type of
F was never found as a significant factor in predicting AF done
n follow-up.
The other question that I have is more from a technical aspect.
ow can you perform the full maze procedure with a bipolar RF
blation technique? Can you elaborate more about this? And how
any times do you clamp and ablate with the RF technique?
Last, it is kind of surprising to find such a stark difference
etween the two RF devices. Can you share with us your thoughts
bout why it happens?
Dr Stulak. Dr Ad, I appreciate your questions. It is difficult at
imes to perform the full Cox maze operation. The lesion sets are
s close as they can be. The connecting lesion down to the mitral
nnulus from the encircling pulmonary vein lesion is the hardest
ne, and a lot of times the surgeons do what they can, but then use
ryolesions as part of this lesion.
Dr Ad. Did you use cryolesions or not?
Dr Stulak. We did, at the mitral annulus and then at the
ricuspid annulus, as described. We did our best to make the
onnecting lesion to the mitral annulus.
In terms of number of burns, with the AtriCure device, typi-
ally the surgeons at the Mayo Clinic apply two burns with each
esion set.
Dr Ad. What about the duration of AF before surgery? That isThe Journal of ThoracicDr Stulak. We did not identify that in our biatrial experience
o be a predictor of failure, only left atrial size and the presence of
oncomitant mitral valve surgery. In this study, patients in the CS
roup actually had a longer preoperative duration of their arrhyth-
ia, which was not significant. This clinical characteristic did not
eem to have any impact in this study, nor was that found to be
ignificant in our biatrial CS experience. This is an important point
hat I failed to include in my presentation.
Dr Shelly C. Lall (St Louis, Mo). I would like to applaud you,
r Stulak, and your colleagues for completing this study and
resenting your data today. I have one question for you. Did the
ame surgeon that performed the CS procedures also do the RF
blation procedures? If not, could that have influenced your
esults?
Dr Stulak. Dr Lall, I enjoyed your presentation yesterday very
uch and I thank you for your question. There were six different
urgeons performing the RF maze procedure, and these same six
urgeons also performed the CS maze operations. I grant you, the
atients in this series represent the first group of patients on whom
e have used this technology, so of course, the question of a
urgeon or even an institutional learning curve becomes relevant.
e examined our results in terms of the surgeons and examined
hether there were different freedom from AF rates for each, and
here was no difference.
Dr Weisel. But the same surgeon did both procedures? That
as her question.
Dr Stulak. All the surgeons at the Mayo Clinic have performed
oth operations.
Dr John Pepper (London, United Kingdom). Did you examine
trial transport or the pattern of ventricular filling and compare it
ith the two groups?
Dr Stulak. No, sir. That is very important. We did not. We
trictly looked at freedom from AF.
Dr Pepper. Getting a nice pretty electrocardiogram is one
hing, but altering atrial transport is another.
Dr Stulak. Point very well taken.
Dr John D. Puskas (Atlanta, Ga). Dr Stulak, the issues of
ransmurality are foremost in our minds. Your institution has
rovided some of the data demonstrating that transmurality can be
ery reliably achieved with bipolar RF. If we are achieving trans-
urality with bipolar RF, and we have to assume we are achieving
ransmurality with a CS technique, why is there a difference in
hese outcomes? Are we now to go back and doubt or question our
ransmurality data with either technique, or is it something differ-
nt about the healing mechanism after an RF injury versus a CS
njury, or is this simply some sort of an anomaly and we are not to
raw any conclusion about the efficacy of RF?
Dr Stulak. Outstanding question. I think that the key is trans-
urality. Studies have shown that conduction block during surgery
oes not necessarily equate with transmurality and also that trans-
urality histologically does not equate with clinical success. I
hink we do not have a complete understanding of what is at play.
ome studies have shown that transmurality cannot be achieved
ntil some weeks or months after the operation. I think there is ahe most important factor in predicting failure. lot about “transmurality” that we don’t understand.and Cardiovascular Surgery ● Volume 133, Number 4 1027
